P399. Testing patients initiating anti-TNFα agents for mycobacterial infection using interferon-gamma release assays (IGRA): The combined experience of a large dermatology and Inflammatory Bowel Disease service
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.